They found that a 6 mg daily dose of dexamethasone, used to reduce inflammation in diseases such as arthritis, reduced the death rate among critically ill COVID-19 patients in hospitals by about a third.
“Given the rapid spread of the Omicron variant, we can expect patients with severe COVID-19 to be hospitalized for a while,” said Peter Horby, a professor at Oxford University who co-led the study.
“So it is very important that we continue RECOVERY to compare a higher dose of 20 mg dexamethasone given once a day for five days, followed by 10 mg once a day for another five days, with the usual low dose treatment.
Process is supported by the UK government and Microsoft billionaire Bill Gates and his ex-wife Melinda French’s charity.
Last week, scientists began investigating GSK and Vir Biotechnology’s antibody-based drug COVID19 as a possible treatment for hospital patients.